The COVID-19 epidemic: 68 newly diagnosed local cases and 22 asymptomatic infections in 31 provinces, autonomous regions and municipalities
From 0-24 o'clock on November 4, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps reported 78 new confirmed cases. Among them, 10 cases were imported from abroad (3 cases in Shanghai, 3 cases in Guangxi, 1 case in Tianjin, 1 case in Liaoning, 1 case in Guangdong, 1 case in Yunnan), including 1 case from asymptomatic infection to confirmed case (in Guangxi);
There were 68 cases (28 in Heilongjiang, all in Heihe City; 10 in Hebei, including 9 in Shijiazhuang City and 1 in Xinji City; 8 in Liaoning, all in Dalian; 5 in Henan, all in Zhengzhou; 5 in Gansu, Among them, there are 4 cases in Lanzhou City and 1 case in Tianshui City; 4 cases in Ningxia, all in Yinchuan City; 2 cases in Inner Mongolia, all in Alxa League; 2 cases in Jiangxi, all in Shangrao City; 2 cases in Sichuan, all in Chengdu; Guizhou 1 Cases, in Zunyi City; 1 case in Yunnan, in Dehong Dai and Jingpo Autonomous Prefecture), including 4 cases from asymptomatic infections to confirmed cases (all in Henan). There were no new deaths. One new suspected case was an imported case (in Shanghai).
29 new cases were cured and discharged on the same day, and 1990 close contacts were released from medical observation. There were 1 more severe cases than the previous day.
There are 373 confirmed cases imported from abroad (including 2 severe cases) and 4 suspected cases. A total of 9,697 confirmed cases, a total of 9,324 cured and discharged cases, and no deaths.
As of 24:00 on November 4, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,129 confirmed cases (including 37 severe cases), 91,840 cured and discharged cases, and 4,636 deaths. , A total of 97,605 confirmed cases have been reported, and there are 4 suspected cases. A total of 1,272,333 close contacts have been traced, and 45,386 close contacts are still under medical observation.
31 provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps reported 42 new cases of asymptomatic infections, including 20 imported cases and 22 local cases (9 cases in Henan, all in Zhengzhou; 8 cases in Liaoning, all in Dalian) 3 cases in Jiangxi, all in Shangrao City; 2 cases in Chongqing, including 1 in Shapingba District and 1 in Yubei District); 5 cases were converted to confirmed cases on the same day (1 case imported from abroad); 17 cases were lifted from medical observation on the same day (imported overseas 14 cases); 426 cases of asymptomatic infections still under medical observation (348 cases imported from abroad).
A total of 28,866 confirmed cases have been notified from Hong Kong, Macau and Taiwan. Among them, there were 12,359 cases in Hong Kong Special Administrative Region (12,035 discharged cases and 213 deaths), 77 cases in Macau Special Administrative Region (75 discharged cases), and 16,430 cases in Taiwan (13,742 discharged cases and 847 death cases).
The editor reminds you to wear a mask when you go out, avoid gatherings in crowded places, and avoid all group activities as much as possible. Only when we are united can we defeat the virus and overcome difficulties.
Looking for chemical products? Let suppliers reach out to you!
2026-05-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
When medical innovation enters the 'inflection point', the 'break' and 'establishment' of AstraZeneca CICC Medical Industry Fund
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
Recommend Reading
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
Geopolitical Deadlock and Tightening Inventories Drive Crude Oil Prices Higher on Friday
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin
-
Short-term correction in lithium carbonate, medium to long-term logic remains unchanged
-
Premium Global Chemical Sourcing Requests (5-9 Jan, 2026)
-
Kemira Acquires AquaBlue